Daily as of 3 Nov 16:00 ET
- Price
- between the two $44.83 vs 50 $48.07 / 200 $42.92
- Projection
- 💀Death cross estimated in 14 to 20 bars
- Test
- No active test
- Last cross
- 🟨Golden cross 20 Jan 2026 · projected 5 bars out
ELVN | Enliven TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$44.83
+$0.20 (+0.45%)
Enliven Therapeutics (ELVN) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2024.
Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Jan 2026, but the two have been closing on each other and a death cross is projected within 20 bars. Price sits between the 50 and the 200 on the daily and the 4-hour.
Timeframe summary
Weekly
No weekly data
4-hour as of 3 Nov 13:30 ET
- Price
- between the two $45.61 vs 50 $42.46 / 200 $50.62
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 8 Oct 2026 · projected 30 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 8 Oct 2026 | 💀Death | 4-hour | 30 bars out | Not tested |
| 20 Jan 2026 | 🟨Golden flat | daily | 5 bars out | Not tested |
| 31 Dec 2025 | 💀Death moderate | daily | 15 bars out | 1 bar cross test |
| 27 Oct 2025 | 🟨Golden moderate | daily | 6 bars out | 2 bar cross test |
| 28 Jan 2025 | 💀Death | daily | 24 bars out | 1 bar cross test |
About ELVN
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$55.2M
4-hour coverageYes, since Oct 2025
History on recordSince 2024
SectorHealthcare
Cap bandmid